Unlock instant, AI-driven research and patent intelligence for your innovation.

Bacterial secretome for use in the treatment of skin lesions

a technology of skin lesions and secretomes, applied in the field of skin lesions treatment, can solve the problems of unsightly, mostly permanent visible marks, and cosmetic problems of healing

Active Publication Date: 2020-01-30
PIERRE FABRE DERMO COSMETIQUE CORP
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes the use of a basic buffer to improve the solubility and stability of proteins and peptides in solution. This buffer can also prevent the proteins from clumping together over time. Additionally, the patent describes how the bacterial secretome can be used to treat skin lesions and improve skin healing and recovery. The technical effects of this patent are improved protein solubility, stability, and treatment of skin lesions.

Problems solved by technology

Healing also poses cosmetic problems when healing defects, or poor healing, cause unsightly and mostly permanent visible marks such as thick scars or keloids.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bacterial secretome for use in the treatment of skin lesions
  • Bacterial secretome for use in the treatment of skin lesions
  • Bacterial secretome for use in the treatment of skin lesions

Examples

Experimental program
Comparison scheme
Effect test

example 1

F BACTERIUM LMB64

[0117]By way of non-limiting example, preferred culture media contain ammonium chloride, magnesium sulphate and yeast extract. It should also be noted that, as arises from application WO2012 / 085182, among others, other similar media may be used and must thus be regarded as forming an integral part of the present description. Any adaptation by persons skilled in the art must also be regarded as part of the invention.

[0118]An exemplary culture process is described below. It should be recalled here that this example is for illustrative purposes only and must in no way be regarded as limiting.

[0119]Strain LMB64 is grown in three steps, namely a first inoculum, a pre-culture (or pre-fermentation) in batch mode and finally a culture but in fed-batch mode (addition of glucose).

[0120]Inoculum:

[0121]A tube of WCB LMB64 is used to inoculate an Erlenmeyer flask containing 1000 mL of sterile medium. The Erlenmeyer flask is then placed in the incubator shaker and shaken. When th...

example 2

N OF THE SECRETOME

[0136]The example below is given by way of illustration of a preferred embodiment, but must not be regarded as limiting.

[0137]The secretome is obtained, generally, after centrifugation of the result of the culture step in order to remove cells, surface proteins and proteins located in the periplasmic space of the bacterium. This centrifugation step is followed by an addition of a Tris-arginine basic buffer to the supernatant. A last step of filtration of the supernatant is also possible. Any adaptation by persons skilled in the art must also be regarded as part of the invention.

[0138]Centrifugation:

[0139]The transfer line from the fermenter to the centrifuge is sterilized. The fermentation must is then separated by continuous centrifugation on a centrifuge. Centrifugation is performed at 150 L / h (±30 L / h) with a bowl rotation speed of 10900±1000 rpm. The supernatant is collected in a container fitted with a disposable pouch. The weight of the supernatant is measure...

example 3

THE SECRETOME ON PROLIFERATION OF NORMAL HUMAN FIBROBLASTS

[0146]The technique used is that of incorporation of a nucleotide, 5-bromo-2′-deoxyuridine (BrdU), a thymidine analogue, in the DNA of S-phase cells, at 37° C. This technique allows quantification of the cells whose progression in the cell cycle is characteristic of a proliferative cell (S or DNA synthesis phase).

[0147]Fibroblasts are seeded in a 96-well plate and then incubated for 72 h in the presence of the compounds to be tested, EGF as positive control and 0.4, 0.6 and 1% secretome. BrdU incorporation is performed during the last 24 h and is quantified using the BrdU ELISA kit (item no. 11647229001, Roche Diagnostics).

[0148]The % of the control is calculated according to the formula:

(Value / mean of the control)×100

[0149]Stimulation in % is calculated according to the formula:

Mean Stimulation in %=(Mean(Value / mean of the control)×100)−100

[0150]SEM=standard dev / √n

[0151]Statistical analyses are performed using Student's t-te...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a novel use of a bacterial secretome in the field of the treatment of skin lesions and more particularly of wound healing. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial secretome as active agent.

Description

FIELD OF THE INVENTION[0001]The present invention relates to a novel use of a bacterial secretome in the field of the treatment of skin lesions and more particularly of wound healing. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial secretome as active agent.PRIOR ART[0002]Wound healing is a complex and dynamic biological process that involves the interaction of many local and systemic factors in normal tissue repair. Healing progresses in three interdependent phases: haemostasis and inflammation, proliferation and remodelling (General principles of wound healing. Witte M B, Barbul A. Surg Clin North Am. 1997 June; 77(3):509-28.). Proliferation involves three clearly observable processes: granulation, contraction and re-epithelialization.[0003]During granulation, cells involved in the repair process are observed to proliferate and migrate toward the wound bed. For example, macrophages, fibroblasts and endothelial cells are found there...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/74A61K33/30A61K33/34A61Q19/08A61K8/99C12N1/20
CPCC12R1/36A61K33/30A61K33/34A61K35/74C12N1/20A61K8/99A61Q19/08A61Q19/00A61P17/00A61P17/02C12R2001/36C12N1/205A61K2300/00
Inventor CASTEX-RIZZI, NATHALIEGALLIANO, MARIE FLORENCEHERNANDEZ-PIGEON, HÉLÈNE
Owner PIERRE FABRE DERMO COSMETIQUE CORP